Clopidogrel use and clinical events after drug-eluting stent implantation: Findings from the HealthCore Integrated Research Database
Authors:
- Lesley H. CurtisLCLesley H. Curtis
- 1 March 2010
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 159 (3) , 462-470.e1
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Long-Term Safety and Efficacy of Drug-Eluting StentsCirculation, 2007
- Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting StentsNew England Journal of Medicine, 2007
- Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in SwedenNew England Journal of Medicine, 2007
- Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal StentsNew England Journal of Medicine, 2007
- Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary StentsNew England Journal of Medicine, 2007
- A Pooled Analysis of Data Comparing Sirolimus-Eluting Stents with Bare-Metal StentsNew England Journal of Medicine, 2007
- Incidence, Timing, and Correlates of Stent Thrombosis With the Polymeric Paclitaxel Drug-Eluting StentJACC, 2007
- Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent ImplantationJAMA, 2007
- Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting StentsJACC, 2006
- What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?JACC, 2005